Literature DB >> 26201772

The risk factors and diagnosis of cholangiocarcinoma.

Christopher A Wadsworth1, Adrian Lim2, Simon D Taylor-Robinson3, Shahid A Khan1.   

Abstract

Cholangiocarcinoma (CC) is a generally fatal malignancy of the biliary tree. Its incidence is increasing worldwide. Unfortunately, the diagnosis of CC frequently occurs late in the course of the disease, which contributes to the high mortality rate. Securing the diagnosis can prove difficult and may require a combination of imaging modalities, serum markers, and tissue sampling. Even with current best practice accurate diagnosis and staging is often elusive. We review current trends in the epidemiology of CC, current best practice in its diagnosis, and some of the emerging technologies and systems that may lead to improved diagnosis, staging, and, perhaps, outcome.

Entities:  

Keywords:  Bile duct; Biliary; Cancer; Cholangiocarcinoma; Diagnosis; Management; Pathogenesis

Year:  2012        PMID: 26201772     DOI: 10.1007/s12072-012-9407-y

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  153 in total

Review 1.  Early detection and treatment of cholangiocarcinoma.

Authors:  G J Gores
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

2.  Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.

Authors:  H Suzuki; S Isaji; C Pairojkul; T Uttaravichien
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

3.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Authors:  Abdul M Oseini; Roongruedee Chaiteerakij; Abdirashid M Shire; Amaar Ghazale; Joseph Kaiya; Catherine D Moser; Ileana Aderca; Teresa A Mettler; Terry M Therneau; Lizhi Zhang; Naoki Takahashi; Suresh T Chari; Lewis R Roberts
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

4.  Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis.

Authors:  A Rumalla; T H Baron; O Leontovich; L J Burgart; R F Yacavone; T M Therneau; P C de Groen; T J Sebo
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

5.  Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.

Authors:  J E Lopera; J A Soto; F Múnera
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

6.  Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.

Authors:  Hanne Prytz; Susanne Keiding; Einar Björnsson; Ulrika Broomé; Sven Almer; Maria Castedal; Ole Lajord Munk
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach.

Authors:  Emmanuel E Zervos; Dana Osborne; Steven B Goldin; Desiree V Villadolid; Donald P Thometz; Alan Durkin; Larry C Carey; Alexander S Rosemurgy
Journal:  Am J Surg       Date:  2005-11       Impact factor: 2.565

Review 8.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

9.  Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.

Authors:  Yasser H Shaib; Jessica A Davila; Louise Henderson; Katherine A McGlynn; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

10.  Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients.

Authors:  J H Helzberg; J M Petersen; J L Boyer
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

View more
  5 in total

Review 1.  Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.

Authors:  Xiao-Hua Ye; Jia-Ping Huai; Jin Ding; Yan-Ping Chen; Xue-Cheng Sun
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 2.  Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.

Authors:  Thomas Hughes; Thomas O'Connor; Anchalee Techasen; Nisana Namwat; Watcharin Loilome; Ross H Andrews; Narong Khuntikeo; Puangrat Yongvanit; Paiboon Sithithaworn; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2017-08-10

3.  Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma.

Authors:  Jingwen Hua; Shiniao Li; Changwen Huang
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

4.  Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.

Authors:  Céline Demarez; Catherine Hubert; Christine Sempoux; Frédéric P Lemaigre
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

5.  The multidisciplinary team meeting in the UK from the patients' perspective: comments and observations from cholangiocarcinoma patients and their families.

Authors:  Helen Morement; Rachel Harrison; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2017-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.